RFP ANNOUNCEMENT: Reagent Resource Support Program for AIDS Vaccine Development: RFP-NIAID-DAIDS-NIHAI2010086

Notice Number: NOT-AI-10-032

Key Dates
Release Date: May 18, 2010

RFP Available Electronically:  Estimated April 27, 2010

RECEIPT DATE: June 28, 2010

Issued by
National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov)


This requirement is a re-competition of contract number N01-AI-30018; Quality Biological, Inc.

The discovery and development of an AIDS vaccine is among the highest research priorities of the National Institute of Allergy and Infectious Diseases (NIAID), and among the principal missions of NIAID’s Division of AIDS (DAIDS).  To support this mission, the incumbent Contractor provides high quality, novel, and targeted reagents, assays and services for use by the HIV/AIDS vaccine research community. Specific projects have included producing, purchasing and providing overlapping peptide sets for SIV/SHIV and HIV, polyclonal and monoclonal antibodies, procuring SIV and SHIV challenge stocks, and supporting the repeated and extensive proficiency testing/standardization of the widely used TZM-bl neutralization assay.

The purpose of the proposed contract will be to produce, procure, store, ship, and maintain an up-to-date inventory of high-quality reagents and assays in support of preclinical and clinical AIDS vaccine research.

To fulfill the technical requirements, the Contractor shall: 1) procure, purify, and test reagents for the DAIDS Vaccine Research Program, including, for example: viral proteins and peptides, virus stocks, monoclonal and polyclonal antibodies, topical microbicides, vaccine vectors, vaccine adjuvants and cytokines, and any additional reagents deemed necessary for the NIAID DAIDS Vaccine Research Program; 2) perform genetic cloning and sequencing; 3) acquire the needed reagents, assays, and/or services used to evaluate AIDS vaccine safety and immunogenicity; 4) analyze all reagents for purity and integrity, and provide for their quality control and assurance; and 5) provide for receipt and inventory tracking, storage, maintenance, and distribution of all reagents. 

It is anticipated that one cost reimbursement, term type contract will be awarded for a 1-year Base period plus six 1-year options for a possible total period of performance of 7 years beginning on or about April 1, 2011. The performance requirement will be for the delivery of 1.9 full time equivalents (FTEs) per year for the base period (Year 1) and option periods (Years 2 through 7), which may be unilaterally exercised by the Government.  In addition to the services outlined above to be provided in the base requirement, Options for additional services under the contract may be exercised at the discretion of the Government to provide an increased level of effort to meet unanticipated needs for acquiring reagents, assays, or technologies.  These Options provide for an increase in Level-of-Effort by the following number of FTEs that allow for the expansion of effort in multiple increments as needed to address unanticipated needs: Options 7-20: Increase to Level-of-Effort by .40 FTEs up to 2 times per year; Options 21-34: Increase to Level-of-Effort by .60 FTEs up to 2 times per year.  The Government reserves the right to exercise Options for Increased Services in any year of the contract (e.g., years 1 through 7 of the contract period of performance).  These Options can be exercised up to two times each within each performance year with a maximum increase of 2.0 FTE per performance year.

The NAICS Code is 541712 with a size standard of 500 employees.

The anticipated period of performance is April 1, 2011 through March 31, 2012 with 1 year options to extend the period for six additional years through March 31, 2018. 

Any responsible offeror may submit a proposal which will be considered by the Agency. This RFP will be available electronically on/about April 27, 2010, and may be accessed through the NIAID Office of Acquisitions (OA) Home Page at http://www.niaid.nih.gov/contract and through FedBizOpps http://www.fedbizopps.gov/.  This notice does not commit the Government to award a contract.  No collect calls will be accepted.  No facsimile transmissions will be accepted.


Direct inquiries and technical issues to:

Susan Breland
Contract Specialist
Office of Acquisitions, Division of Extramural Activities, NIAID, NIH, DHHS
6700-B Rockledge Drive Room 3221, MSC 7612 (Express mail:  Use Zip Code 20817-7612)
Phone: 301-496-0612
Fax: 301-480-4675

Michelle L. Scala
Contracting Officer
Office of Acquisitions, Division of Extramural Activities, NIAID, NIH, DHHS
6700-B Rockledge Drive Room 3106, MSC 7612 (Express mail:  Use Zip Code 20817-7612)
Phone: 301-451-3693
Fax: 301-480-4675
Contracting Office Address

Department of Health and Human Services
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Division of Extramural Activities
Office of Acquisitions
6700-B Rockledge Drive
Room 3214, MSC 7612
Bethesda, MD 20892-7612


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.